SEC Comment Letter 0000000000-25-001156 to Cellectar Biosciences, Inc. (CLRB)
Cellectar Biosciences, Inc.
Date: Feb. 3, 2025 · CIK: 0001279704 · Accession: 0000000000-25-001156
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284580
Letter
February 3, 2025 James V. Caruso Chief Executive Officer Cellectar Biosciences, Inc. 100 Campus Drive Florham Park, NJ 07932 Re:Cellectar Biosciences, Inc. Registration Statement on Form S-1 Filed January 29, 2025 File No. 333-284580 Dear James V. Caruso: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Kostian Ciko, Esq.
Show Raw Text
February 3, 2025
James V. Caruso
Chief Executive Officer
Cellectar Biosciences, Inc.
100 Campus Drive
Florham Park, NJ 07932
Re:Cellectar Biosciences, Inc.
Registration Statement on Form S-1
Filed January 29, 2025
File No. 333-284580
Dear James V. Caruso:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Kostian Ciko, Esq.